Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions

Affiliations

¹ Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
² QVQ Holding BV, Utrecht, Netherlands.
³ Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
⁴ Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States.
⁵ Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands.
⁶ VerLin BV, Utrecht, Netherlands.
⁷ Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.

Published Erratum

Angela I Schriek et al. Front Immunol. 2022.

. 2022 Nov 22:13:1091668.

doi: 10.3389/fimmu.2022.1091668. eCollection 2022.

¹ Department of Medical Microbiology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
² QVQ Holding BV, Utrecht, Netherlands.
³ Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
⁴ Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, United States.
⁵ Department of Biology, Faculty of Sciences, Utrecht University, Utrecht, Netherlands.
⁶ VerLin BV, Utrecht, Netherlands.
⁷ Department of Experimental Immunology, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.893648.].

Keywords: Fc fusion; Fc-mediated effector functions; HIV-1; nanobodies; neutralization.

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.
Schriek AI, van Haaren MM, Poniman M, Dekkers G, Bentlage AEH, Grobben M, Vidarsson G, Sanders RW, Verrips T, Geijtenbeek TBH, Heukers R, Kootstra NA, de Taeye SW, van Gils MJ. Schriek AI, et al. Front Immunol. 2022 May 16;13:893648. doi: 10.3389/fimmu.2022.893648. eCollection 2022. Front Immunol. 2022. PMID: 35651621 Free PMC article.